Alan Moy, President and Chief Executive Officer, Cellular Engineering Technologies Inc.
Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 1/18/15 and contains information from public web pages and contributions from the ZoomInfo community.
User Verified.

President and Chief Executive Off...

Phone: (319) ***-****  HQ Phone
Cellular Engineering Technologies Inc.
2660 Crosspark Road Suite 135
Coralville , Iowa 52241
United States

Company Description: Cellular Engineering Technologies (CET) is an emerging biotechnology company in tissue engineering focused on developing novel technologies to expedite the drug...   more

Board Memberships and Affiliations


  • bachelor's degree , biochemistry
    University of California , Davis
  • M.D. , Medicine
    Creighton University
55 Total References
Web References
CET - About CET, 18 Jan 2015 [cached]
Alan Moy, MD Chief Executive Officer and Founder
Alan Moy, M.D., a physician-scientist, was previously on faculty for 13 years at the University of Iowa Department of Internal Medicine and Biomedical Engineering. Dr. Moy founded the company in 2000. Dr. Moy received a Bachelor's degree in Biochemistry from the University of California, Davis and an M.D. from Creighton University. He received postgraduate education in Internal Medicine from St. Louis University and completed a fellowship in Pulmonary Medicine and Critical Care Medicine at the University of Iowa. Dr. Moy's research expertise is in the area of vascular biology and tissue engineering. Dr. Moy is also listed in the 2010 Who's Who in America and is listed in 2011 as a Leading Physician of the World by the International Association of Healthcare Professions.
Cellular Engineering ..., 1 May 2014 [cached]
Cellular Engineering Technologies was founded by Dr. Alan Moy, a physician-scientist with expertise in stem cell technology and cancer biology. CET is a leader in adult stem cell technology whose mission is to decrease the cost and increase the efficiency of drug development. Using its expertise, CET has now developed the next generation of cancer technology to advance the field. CET is partnering with JP2MRI to create a new paradigm in cancer diagnosis, treatment and drug development. "Cancer patients are subjected to some of the greatest challenges in healthcare," says Dr. Moy. Chemotherapy has only modestly improved the 5-year survival rate by 2 percent for adult solid cancers. The healthcare system spends over $110,000 a year to treat a cancer patient with chemotherapy, four times the amount for cancer patients not receiving chemotherapy. It takes 12-15 years and over 1 billion dollars to bring a new cancer drug to market and there is a 95 percent failure rate associated with the process. Chemotherapy has serious side effects and is frequently administered without any rigorous testing to specifically identify which cancer drugs will be effective or not. "Genetic testing has been widely pursued to improve diagnostic testing and treatment but there are major deficiencies in such technology," says Dr. Moy.
The John Paul II Medical Research ..., 27 Aug 2014 [cached]
The John Paul II Medical Research Institute, founded in 2008 by Dr. Alan Moy, an Iowa City pulmonologist, has gotten “hundreds of thousands” of dollars in donations from people who want to support research on Amyotrophic Lateral Sclerosis (ALS), but don't want the research done with human embryos, said CEO Jay Kamath.
Moy, the scientific director, collects tissue samples from patients who want to participate in research.
Cellular Engineering ..., 24 July 2014 [cached]
Cellular Engineering Technologies was founded by Dr. Alan Moy, a physician-scientist with expertise in stem cell technology and cancer biology. Dr. Alan Moy, also the founder of JP2MRI, is a pulmonologist who practices through Pulmonary Associates at Mercy Hospital in Iowa City.
"Cancer patients are subjected to some of the greatest challenges in healthcare," Dr. Moy explained.
Dr. Alan Moy, CEO and ..., 24 Feb 2013 [cached]
Dr. Alan Moy, CEO and Co-Founder of CET said, "The collaboration with the JP2MRI will allow CET to provide scientists with the tools to accelerate drug discovery and advance personalized medicine."
CET is a stem cell biotech company co-founded by Dr. Alan Moy and whose mission is to fundamentally transform patient therapy by making drug discovery and the biomanufacturing process quicker, less expensive, more personalized, innovative, and regenerative through the use of human cells. CET's manufacturing facility is located in Coralville, IA.
Other People with the name "Moy":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.